Genomic epidemiology of emerging terbinafine-resistant Trichophyton indotineae

Johanna Rhodes,Chloe Sui Ting Hui,Sarah Delliere,Richard Summerbell,James Scott,Amtoj Kaur,Richard Barton,Rodrigo Leitao,Samuel Hemmings,Rebeca Goiriz,Jonathan Lambourne,Rhys Farrer,Silke Schelenz,Roderick Hay,Andrew Borman,Anuradha Chowdhary,Alireza Abdolrasouli,Matthew Fisher

DOI: https://doi.org/10.1101/2024.10.29.620818

2024-11-03

Abstract:Dermatophyte skin infections affect around a quarter of the world's population and are a growing public health concern due to increasing incidence of novel species causing severe infections that are resistant to antifungal treatments. Trichophyton species cause the greatest burden of dermatophytosis worldwide, with the T. mentagrophytes species complex being particularly associated with the emergence of new aggressive infections. One emerging species, T. indotineae (originally T. mentagrophytes genotype VIII) is notable for the extensive nature of the often inflammatory infection, its clinical resistance to terbinafine antifungal treatment, and its rapid global spread. To better understand the epidemiology of this disease, we sourced isolates from severe cases of dermatophytosis in the United Kingdom, Ireland, France, Canada and India for the period 2018-2023, including the type strain from Japan. We used whole-genome sequencing to confirm 90 isolates were T. indotineae, and antifungal susceptibility testing indicated that over half of these (62%) were resistant to terbinafine (MIC >=1 mg/L). Pairwise genetic distances showed very high identity with only 147 (1-414) SNPs separating isolates that were nested within a monophyletic phylogeny, supporting a single evolutionary origin of T. indotineae. That no clear geographic clustering of isolates was observed confirms the rapid transcontinental spread of T. indotineae from its likely centre of diversity in Asia. Genome-wide analyses identified multiple non-synonymous SNPs in SQLE (ERG1), the squalene epoxidase target of terbinafine, that were associated with terbinafine in vitro resistance >=1 mg/L. However, five isolates exhibited high MIC values without SQLE mutations, suggesting the presence of alternative resistance mechanisms. Our findings highlight the importance of better genomic surveillance to understand and manage this severe and rapidly emerging terbinafine-resistant dermatophyte.

Genomics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is related to the drug resistance and epidemiological characteristics of a fungus named **Trichophyton indotinea**. Specifically, the research aims to:

1. **Confirm the global distribution and genetic diversity of T. indotinea**: By collecting clinical isolates from different countries and regions, use whole - genome sequencing (WGS) technology to analyze the genetic relationships among these isolates, confirm whether they truly belong to T. indotinea, and explore their spread on a global scale.

2. **Evaluate the resistance of T. indotinea to terbinafine**: Terbinafine is a commonly used antifungal drug, but in recent years, it has been found that T. indotinea shows a relatively high resistance to this drug. The research determines the minimum inhibitory concentration (MIC) of the isolates to terbinafine through antifungal susceptibility testing (AFST) and explores the molecular mechanisms of drug resistance.

3. **Explore the molecular basis of drug resistance**: By analyzing genomic data, especially by identifying single nucleotide polymorphisms (SNPs) in genes encoding terbinafine targets (such as the SQLE gene), to understand the association between these variations and drug resistance.

4. **Understand the population structure and transmission pattern of T. indotinea**: Through genetic analysis and the construction of phylogenetic trees, study the genetic similarities and differences of T. indotinea among different geographical regions, as well as its possible origin and transmission routes.

In summary, this research aims to comprehensively understand the drug resistance and transmission characteristics of T. indotinea through comprehensive genomics and epidemiological methods, providing a scientific basis for future clinical treatment and public health management.